CD8A and neoplasm: Investigations of immunocompetent and immunodeficient mice have shown that a responsive immune system is vital for the optimal efficacy of IRE [100], although a murine sarcoma model did not reveal any tumor-infiltrating CD4+ or CD8+ T lymphocytes within six hours after IRE [101].